Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 34 | 2023 | 998 | 9.970 |
Why?
|
| Apolipoprotein E4 | 14 | 2023 | 235 | 4.560 |
Why?
|
| Alzheimer Disease | 18 | 2023 | 1981 | 3.800 |
Why?
|
| Aged | 68 | 2023 | 8397 | 2.750 |
Why?
|
| Cognition | 26 | 2023 | 1263 | 2.720 |
Why?
|
| Cognition Disorders | 13 | 2018 | 939 | 2.660 |
Why?
|
| Stroke | 6 | 2023 | 254 | 2.590 |
Why?
|
| Female | 73 | 2023 | 13844 | 2.130 |
Why?
|
| Humans | 90 | 2023 | 25178 | 2.010 |
Why?
|
| Male | 63 | 2023 | 13545 | 1.980 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 244 | 1.890 |
Why?
|
| Longitudinal Studies | 22 | 2022 | 1299 | 1.650 |
Why?
|
| Cohort Studies | 19 | 2023 | 1756 | 1.600 |
Why?
|
| Activities of Daily Living | 8 | 2018 | 498 | 1.600 |
Why?
|
| Exercise | 9 | 2023 | 447 | 1.580 |
Why?
|
| Aging | 10 | 2023 | 1520 | 1.560 |
Why?
|
| White Matter | 3 | 2022 | 143 | 1.550 |
Why?
|
| Biomarkers | 8 | 2023 | 537 | 1.530 |
Why?
|
| Population Surveillance | 3 | 2021 | 93 | 1.470 |
Why?
|
| Chicago | 19 | 2022 | 782 | 1.390 |
Why?
|
| Risk Factors | 20 | 2023 | 2166 | 1.390 |
Why?
|
| Aged, 80 and over | 29 | 2022 | 4503 | 1.310 |
Why?
|
| Vitamin E | 2 | 2023 | 25 | 1.300 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 20 | 1.270 |
Why?
|
| Dementia | 8 | 2022 | 516 | 1.200 |
Why?
|
| Mortality | 4 | 2021 | 81 | 1.070 |
Why?
|
| tau Proteins | 3 | 2023 | 216 | 1.050 |
Why?
|
| Disease Progression | 9 | 2019 | 649 | 1.040 |
Why?
|
| Genotype | 6 | 2018 | 338 | 1.020 |
Why?
|
| Alleles | 8 | 2023 | 209 | 1.000 |
Why?
|
| Prospective Studies | 11 | 2023 | 1589 | 0.930 |
Why?
|
| Disability Evaluation | 4 | 2014 | 276 | 0.910 |
Why?
|
| Whole Grains | 1 | 2023 | 6 | 0.900 |
Why?
|
| Neuropathology | 3 | 2021 | 82 | 0.840 |
Why?
|
| Incidence | 10 | 2023 | 664 | 0.810 |
Why?
|
| Vitamin D | 1 | 2022 | 36 | 0.800 |
Why?
|
| United States | 11 | 2023 | 1899 | 0.790 |
Why?
|
| Depression | 3 | 2014 | 395 | 0.770 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 109 | 0.760 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 75 | 0.760 |
Why?
|
| Healthy Lifestyle | 4 | 2022 | 31 | 0.750 |
Why?
|
| Blood Pressure | 2 | 2021 | 200 | 0.740 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 6 | 0.730 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 28 | 0.720 |
Why?
|
| Membrane Proteins | 1 | 2021 | 150 | 0.710 |
Why?
|
| Geriatric Assessment | 4 | 2021 | 201 | 0.650 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1189 | 0.610 |
Why?
|
| Diet | 4 | 2023 | 164 | 0.610 |
Why?
|
| Time Factors | 8 | 2021 | 1327 | 0.570 |
Why?
|
| Art | 1 | 2016 | 1 | 0.560 |
Why?
|
| Music | 1 | 2016 | 18 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 380 | 0.550 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 69 | 0.540 |
Why?
|
| Diabetes Complications | 1 | 2016 | 54 | 0.540 |
Why?
|
| Models, Statistical | 2 | 2021 | 115 | 0.530 |
Why?
|
| Life Style | 5 | 2022 | 183 | 0.520 |
Why?
|
| Obesity | 6 | 2014 | 265 | 0.520 |
Why?
|
| Prevalence | 3 | 2023 | 421 | 0.510 |
Why?
|
| Cognitive Aging | 4 | 2021 | 73 | 0.490 |
Why?
|
| Body Mass Index | 6 | 2018 | 393 | 0.490 |
Why?
|
| Depressive Disorder | 1 | 2015 | 163 | 0.480 |
Why?
|
| Mobility Limitation | 1 | 2015 | 92 | 0.470 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 1621 | 0.470 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 16 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 166 | 0.460 |
Why?
|
| Dopamine Agents | 1 | 2014 | 16 | 0.460 |
Why?
|
| Memantine | 1 | 2014 | 10 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 280 | 0.450 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 327 | 0.450 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 292 | 0.450 |
Why?
|
| Antioxidants | 1 | 2014 | 55 | 0.440 |
Why?
|
| Health Status Disparities | 1 | 2013 | 67 | 0.420 |
Why?
|
| Motor Activity | 1 | 2015 | 305 | 0.420 |
Why?
|
| Memory, Episodic | 3 | 2018 | 114 | 0.410 |
Why?
|
| Diagnosis | 1 | 2011 | 24 | 0.400 |
Why?
|
| Area Under Curve | 1 | 2011 | 52 | 0.390 |
Why?
|
| Medical Informatics | 1 | 2011 | 8 | 0.390 |
Why?
|
| Linear Models | 3 | 2016 | 231 | 0.370 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.370 |
Why?
|
| Independent Living | 3 | 2022 | 305 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2012 | 123 | 0.350 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 438 | 0.340 |
Why?
|
| Age of Onset | 3 | 2014 | 89 | 0.320 |
Why?
|
| Genetic Loci | 3 | 2018 | 54 | 0.310 |
Why?
|
| Middle Aged | 20 | 2019 | 8135 | 0.310 |
Why?
|
| Postmenopause | 7 | 2006 | 49 | 0.290 |
Why?
|
| Memory Disorders | 2 | 2018 | 159 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1113 | 0.270 |
Why?
|
| Neuroticism | 2 | 2023 | 31 | 0.260 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 30 | 0.250 |
Why?
|
| Survivors | 3 | 2022 | 50 | 0.240 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 80 | 0.230 |
Why?
|
| Florida | 1 | 2023 | 21 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 429 | 0.220 |
Why?
|
| Tocopherols | 1 | 2023 | 7 | 0.210 |
Why?
|
| Adult | 10 | 2023 | 7087 | 0.210 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 10 | 0.210 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2011 | 250 | 0.210 |
Why?
|
| Vitamins | 1 | 2022 | 19 | 0.210 |
Why?
|
| Brain Infarction | 1 | 2023 | 73 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 52 | 0.200 |
Why?
|
| Life Expectancy | 1 | 2022 | 19 | 0.200 |
Why?
|
| Age Factors | 2 | 2022 | 720 | 0.200 |
Why?
|
| Loneliness | 1 | 2023 | 54 | 0.200 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2022 | 28 | 0.200 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 39 | 0.200 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 5 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 36 | 0.190 |
Why?
|
| Cost of Illness | 1 | 2021 | 43 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 306 | 0.180 |
Why?
|
| Noise | 1 | 2020 | 20 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 61 | 0.180 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 93 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 133 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 161 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 203 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2017 | 86 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 38 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 212 | 0.160 |
Why?
|
| Hippocampus | 1 | 2020 | 247 | 0.160 |
Why?
|
| Social Networking | 1 | 2018 | 10 | 0.160 |
Why?
|
| Healthy Aging | 1 | 2018 | 11 | 0.160 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 4 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 113 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 22 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 10 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2017 | 243 | 0.150 |
Why?
|
| Nursing Homes | 1 | 2018 | 31 | 0.150 |
Why?
|
| Brain | 3 | 2022 | 1626 | 0.150 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 276 | 0.150 |
Why?
|
| Social Environment | 1 | 2018 | 77 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2019 | 111 | 0.150 |
Why?
|
| Pain Management | 1 | 2019 | 129 | 0.150 |
Why?
|
| Defecation | 1 | 2017 | 4 | 0.150 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 23 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 20 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 82 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 22 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mucormycosis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2017 | 13 | 0.140 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.140 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproduction | 1 | 2016 | 9 | 0.140 |
Why?
|
| Warfare | 1 | 2016 | 10 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 44 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 253 | 0.140 |
Why?
|
| Terrorism | 1 | 2016 | 11 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2022 | 818 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 37 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2015 | 199 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2016 | 1037 | 0.130 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 6 | 0.130 |
Why?
|
| Overweight | 2 | 2014 | 63 | 0.130 |
Why?
|
| Self Report | 1 | 2016 | 199 | 0.130 |
Why?
|
| Insulin | 2 | 2014 | 74 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 60 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 6 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 7 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 11 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 94 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 32 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 156 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 52 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 139 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 157 | 0.120 |
Why?
|
| Demography | 1 | 2014 | 69 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 282 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 171 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2014 | 14 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2014 | 32 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 67 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 61 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 107 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 315 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 219 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2013 | 28 | 0.110 |
Why?
|
| Adenoma | 1 | 2013 | 29 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 187 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2015 | 88 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 309 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 306 | 0.110 |
Why?
|
| Urban Population | 1 | 2013 | 131 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 168 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 121 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 65 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 208 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 53 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 341 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 206 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 44 | 0.100 |
Why?
|
| ROC Curve | 1 | 2011 | 126 | 0.100 |
Why?
|
| Gait | 1 | 2015 | 391 | 0.100 |
Why?
|
| Elder Abuse | 1 | 2011 | 34 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 85 | 0.090 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 217 | 0.090 |
Why?
|
| Testosterone | 3 | 2004 | 26 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2010 | 191 | 0.080 |
Why?
|
| Algorithms | 1 | 2010 | 351 | 0.080 |
Why?
|
| Young Adult | 3 | 2018 | 1749 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 6 | 0.070 |
Why?
|
| Animals | 1 | 2014 | 3377 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 358 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 283 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 16 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 32 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 87 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 10 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 4 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 46 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 88 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 6 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 53 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 100 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 30 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 192 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 467 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 6 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 832 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 50 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 12 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 99 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 343 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 19 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 88 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 116 | 0.050 |
Why?
|
| Autopsy | 1 | 2021 | 336 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 70 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 165 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1232 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 17 | 0.040 |
Why?
|
| Hypertension | 1 | 2021 | 234 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 27 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 17 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 19 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 8 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 36 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 60 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 92 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 20 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 74 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 61 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 122 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 1998 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 104 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 122 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 11 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 18 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 279 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 35 | 0.040 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.040 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.040 |
Why?
|
| Maternal Age | 1 | 2016 | 12 | 0.030 |
Why?
|
| Feces | 1 | 2017 | 108 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 9 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 43 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 50 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 17 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 3 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 13 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 12 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 8 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 539 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 43 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 272 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 185 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 413 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 283 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 302 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 16 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 4 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 173 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 6 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 41 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 41 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3105 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 42 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 179 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 219 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 36 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 127 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 193 | 0.030 |
Why?
|
| China | 1 | 2014 | 50 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 117 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 5 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 58 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 14 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 36 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 120 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 572 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 138 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 42 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 588 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 124 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 115 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 72 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 645 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 289 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 73 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 277 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 195 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 272 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 293 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 140 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 9 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 21 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 39 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 19 | 0.020 |
Why?
|
| Triglycerides | 1 | 2005 | 39 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2004 | 10 | 0.020 |
Why?
|
| Homeostasis | 1 | 2005 | 51 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 44 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 59 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 11 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 23 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 69 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 57 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 57 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 4 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 33 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 75 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 294 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 685 | 0.010 |
Why?
|